Home Page |
References | OMIM | Gene | GeneReviews | HGMD | HGNC |
GENATLAS PHENOTYPE |
last update : 20/10/2006 |
Symbol | AML1 | |||||
Location | 21q22.12 | |||||
Name | sporadic myeloid and lymphoid leukemias | |||||
Corresponding gene | RUNX1 | |||||
Main clinical features |
| |||||
Genetic determination
Related entries
| FPDAML
| Function/system disorder
| hematology | Type
| malignancy
| |
Mechanism(s) |
Gene mutation | Chromosome rearrangement | Effect | Comments |
|  
| translocation
|  
| t(8;21)(q22;q22)in AML M2 subtype, t(16;21)(q24;q22) (CBFB), t(3;21)(q26;q22) in myelodysplasia syndrome (EVI1, MDS1), t(12;21)(p13;q22)in acute lymphoblastic leukemia(ETV6), and others
| various types
|  
|  
| sporadic point mutations in AML M0 subtype, MDS-AML, therapy-related MDS/AML
| amplification
|  
|  
| in a subtype of ALL (iAMP21)
| |
Remark(s) | RUNX1(AML1) is one of the most frequent targets of chromosome translocations associated with leukemia |
Genotype/Phenotype correlations | germline mutations give rise to a familial platelet disoder with ppredisposition to acute myelogenous leukemia FPD/AML |